Top News

Novartis to Acquire Endocyte in Deal Worth $2.1 Billion

Oct 18, 2018

Novartis plans to acquire Endocyte, a biopharmaceutical company, to accelerate the development of innovative radioligand technology for treating cancer.

Sandoz Humira Biosimilar Patent Dispute Resolved

Oct 12, 2018

Novartis’ Sandoz has reached a global patent resolution for Hyrimoz (adalimumab), its biosimilar to AbbVie’s Humira (adalimumab).

Janssen, Arrowhead Enter $3.7-Billion Partnership to Treat Hep B

Oct 10, 2018

The companies will develop and commercialize ARO-HBV, a Phase I/II subcutaneous, ribonucleic acid interference therapy candidate being investigated for the treatment of chronic hepatitis B viral infection.

BioPharm eBooks

Single-Use Systems 2018 eBook
A review of new technologies and processes that are helping to drive the adoption of single-use systems for the commercial production of biologic-based drugs. 

View ebook

 

 

Biopharma News

AbbVie, Morphic Therapeutic Join Forces for Fibrotic Disease Treatments

Oct 19, 2018

The companies will work together to advance a number of Morphic's oral integrin therapeutics for fibrosis-related indications in a deal with $100 million.

Novartis to Acquire Endocyte in Deal Worth $2.1 Billion

Oct 18, 2018

Novartis plans to acquire Endocyte, a biopharmaceutical company, to accelerate the development of innovative radioligand technology for treating cancer.

Roche, Ionis Partner to Develop Eye Disease Treatment

Oct 18, 2018

The companies will work together to develop Ionis-FB-LRx for the treatment of complement-mediated diseases, including Geographic Atrophy (GA), the advanced stage of dry age-related macular degeneration (AMD), in a deal worth $760 million.

Industry News

FDA Promotes Complex Generics and Combination Products

To achieve a more dynamic marketplace, FDA is issuingguidance documents and targeted advisories to support R&D on complex generics and combination products.

EMA Recommends Six Medicines for Approval

The recommended drugs include one biosimilar, two orphan medicines, and three extensions of therapeutic indications.

Politics Drives Direct-to-Consumer Price Disclosure Rule

The US Department of Health and Human Services has published its proposed rule on the disclosure of drug prices, just in time for the November mid-term elections.

Supplier News

AbbVie, Morphic Therapeutic Join Forces for Fibrotic Disease Treatments

The companies will work together to advance a number of Morphic's oral integrin therapeutics for fibrosis-related indications in a deal with $100 million.

Recipharm Releases First Serialized Products to Europe

The contract development and manufacturing organization released its first serialized products to Europe from its facilities in Lisbon, Portugal and Stockholm, Sweden.

MilliporeSigma Wins CPhI Pharma Award for Excellence in Innovation

The company was awarded for excellence in innovation for Parteck MXP Excipient and modified amino acids.

Upstream Processing

A Plastic Pipeline for Commercial Bioprocessing?

The maturation of single-use technologies presents commercial bioprocessing options for small-volume drug products.

APC and Bavarian Nordic Build 500-L Single-Use Biologics Pilot Plant

The companies partnered to build a 500-L single-use pilot-scale plant for biologics production.

Roquette Showcases Biopharma Innovations at CPhI Worldwide 2018

The provider of plant-based ingredients will present recently launched multi-compendial materials for upstream and downstream biopharmaceutical applications.

Downstream Processing

Validating Virus Clearance in a Single-Use System Part 1: Film Adsorption and Virus Inactivation Studies

This article explores the use of single-use mixing technology in a detergent-based virus inactivation step during a monoclonal antibody production process.

A Plastic Pipeline for Commercial Bioprocessing?

The maturation of single-use technologies presents commercial bioprocessing options for small-volume drug products.

APC and Bavarian Nordic Build 500-L Single-Use Biologics Pilot Plant

The companies partnered to build a 500-L single-use pilot-scale plant for biologics production.

Standards/Regulations

USP Proposes a New Chapter for Rapid Sterility Testing

The US Pharmacopeial Convention (USP) is developing a new chapter for rapid sterility testing of short-life products based on the recommendations of a panel of experts and stakeholders.

Study on an Inactivation Evaluation Method of Cleaning Processes for Biopharmaceuticals

This study was successful in establishing a reliable and effective method for evaluating cleaning processes based on risk.

PDA’s New Technical Report Highlights Data Integrity Management System for Pharma Labs

PDA Technical Report 80 (TR 80): Data Integrity in Laboratory Systems is the first in a series of three technical reports PDA will publish on data integrity.

Sponsored Videos

Sponsored eBooks

QbD and PAT in Biopharmaceutical Development
In this eBook, learn how the adoption of QbD and Process Analytical Technology (PAT) as well as Design of Experiments techniques help biopharmaceutical companies improve efficiency and accelerate time to market. 
More eBooks

 

 

 

 

Cell and Gene Therapies

MilliporeSigma Offers Insect Platform for Viral Vaccines and Gene Therapy Development

The company will collaborate with GlycoBac to offer an insect cell line for the development of viral vaccines and gene therapies.

GSK, Hitachi Chemical in T-Cell Manufacturing Pact

The companies signed a three-year clinical manufacturing agreement to manufacture GlaxoSmithKline’s specific peptide enhanced affinity receptor T-cell receptor therapy for United States, Canadian, and European clinical trials.

Janssen, Arrowhead Enter $3.7-Billion Partnership to Treat Hep B

The companies will develop and commercialize ARO-HBV, a Phase I/II subcutaneous, ribonucleic acid interference therapy candidate being investigated for the treatment of chronic hepatitis B viral infection.

Analytics

Almac Invests in Next-Generation Sequencing Capabilities

The company says the new equipment will reduce sample turnaround times and increase variant detection quality and accuracy.

Recent Advances in the Use of Exoglycosidases to Improve Structural Profiling of N-glycans from Biologic Drugs

Analytical exoglycosidases are transitioning from being largely academic tools to being suitable for glycan analytics in biopharmaceutical manufacturing.

Reaction Biology and Promega Partner on Bioassay Tool

The companies collaborated to launch a new cell-based profiling service for biochemical assay.

Formulation

Outsourcing Development: Small-Scale to Commercial

Industry experts discuss the formulation and development issues that should be considered when addressing scale up from small-scale batches to commercial production.

Nanoform Invests in Nanoparticle Technology for Drug Development

The drug particle engineering and nanotechnology company offers a nanotechnology platform that can revive failed drugs in the pharma pipeline.

Thermo Fisher Scientific to Acquire Advanced Bioprocessing Business from BD

Becton Dickinson’s (BD) Advanced Bioprocessing business will be integrated into Thermo Fisher's Life Sciences Solutions segment.

Single-Use Systems

Validating Virus Clearance in a Single-Use System Part 1: Film Adsorption and Virus Inactivation Studies

This article explores the use of single-use mixing technology in a detergent-based virus inactivation step during a monoclonal antibody production process.

A Plastic Pipeline for Commercial Bioprocessing?

The maturation of single-use technologies presents commercial bioprocessing options for small-volume drug products.

APC and Bavarian Nordic Build 500-L Single-Use Biologics Pilot Plant

The companies partnered to build a 500-L single-use pilot-scale plant for biologics production.

mAb Development

Validating Virus Clearance in a Single-Use System Part 1: Film Adsorption and Virus Inactivation Studies

This article explores the use of single-use mixing technology in a detergent-based virus inactivation step during a monoclonal antibody production process.

Assessing Viral Inactivation for Continuous Processing

Testing demonstrates an automated semi-continuous process strategy for viral inactivation with steps that mimic batch processing.

Improving Aggregate Removal to Enhance Clinical Manufacturing of MAbs

Hydrophobic interaction chromatography (HIC) in flow-through mode offers a more efficient and cost-effective polishing/purification process to remove monoclonal antibody aggregates while maintaining purity at ≥99% than a mixed-mode bind/elute procedure.

Vaccine Development

MilliporeSigma Offers Insect Platform for Viral Vaccines and Gene Therapy Development

The company will collaborate with GlycoBac to offer an insect cell line for the development of viral vaccines and gene therapies.

Scientists Develop New Vaccine for Lassa Fever and Rabies

A new investigational vaccine, LASSARAB, shows promise for use against Lassa fever and rabies.

New Analytical Instrument Could Change Vaccine Development Through Faster Viral Detection

Research by Thermo Fisher Scientific and LumaCyte suggests that LumaCyte's Radiance instrument offers the ability to rapidly analyze viral vaccines to speed development and production and ensure their effectiveness.

lorem ipsum